Concepedia

Lily Y. Moy

LY

Statistics

Publications

28

Citations

1.8K

H-Index

19

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Massachusetts Institute of Technology

United States Military Academy

Howard Hughes Medical Institute

Harvard University

Lily Y. Moy is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and immunology.

ORCID

Top concepts

Publications per year

1994–2024

28

Publications

28

Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity

Dohoon Kim, Christopher L. Frank, Matthew M. Dobbin et al. · Neuron · 2008 · 289 citations · Full text

, , +2

Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma

Handan Xiang, Carlo P. Ramil, Josephine Hai et al. · Cancer Immunology Research · 2020 · 254 citations · Full text

p25/Cyclin-Dependent Kinase 5 Induces Production and Intraneuronal Accumulation of Amyloid β<i>In Vivo</i>

Jonathan C. Cruz, Do‐Hoon Kim, Lily Y. Moy et al. · Journal of Neuroscience · 2006 · 202 citations · Full text

Cep120 and TACCs Control Interkinetic Nuclear Migration and the Neural Progenitor Pool

Zhigang Xie, Lily Y. Moy, Kamon Sanada et al. · Neuron · 2007 · 178 citations · Full text

, , +8

Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment

Martin R. Gluck, Lily Y. Moy, Elizabeth Jayatilleke et al. · Journal of Neurochemistry · 2001 · 152 citations · Full text

1–5 of 28